The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Targeting immunosuppressive adenosine in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286
CD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,263
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066
Self-citationA2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Shang, B., Liu, Y., Jiang, S.-J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep15179 · Cited by 985
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Metabolic Reprogramming of Immune Cells in Cancer Progression
Biswas, S. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.001 · Cited by 721
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N. A., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15337 · Cited by 679
Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., & Colgan, S. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215337 · Cited by 660
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Hatfield, S. M., Kjaergaard, J., Lukashev, D., Schreiber, T. H., Belikoff, B., Abbott, R., Sethumadhavan, S., Philbrook, P., Ko, K., Cannici, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1260 · Cited by 600
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Self-citationExtracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 571
Self-citationRegulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P.-C., & Verdeil, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.80 · Cited by 566
Extracellular purines, purinergic receptors and tumor growth
Di Virgilio, F., & Adinolfi, E. (2017) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 559
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Clayton, A., Al-Taei, S., Webber, J., Mason, M. D., & Tabi, Z. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003884 · Cited by 540
Zarek, P. E., Huang, C.-T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008) · Blood · doi:10.1182/blood-2007-03-081646 · Cited by 515
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Loi, S., Pommey, S., Haibe-Kains, B., Beavis, P. A., Darcy, P. K., Smyth, M. J., & Stagg, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222251110 · Cited by 492
Self-citationTargeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Allard, B., Pommey, S., Smyth, M. J., & Stagg, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0545 · Cited by 458
Self-citation(1997) · PubMed · Cited by 433
Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T., Curiel, T. J., & Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3109 · Cited by 432
Adenosine receptors in regulation of dendritic cell differentiation and function
Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., et al. (2008) · Blood · doi:10.1182/blood-2008-02-136325 · Cited by 430
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
Stagg, J., Divisekera, U., Duret, H., Sparwasser, T., Teng, M. W. L., Darcy, P. K., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4246 · Cited by 401
Self-citationOhta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., & Sitkovsky, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00190 · Cited by 398
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
Gupta, P. K., Godec, J., Wolski, D., Adland, E., Yates, K., Pauken, K. E., Cosgrove, C., Ledderose, C., Junger, W. G., Robson, S. C., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005177 · Cited by 396
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Young, A., Ngiow, S. F., Barkauskas, D. S., Sult, E., Hay, C., Blake, S. J., Huang, Q., Liu, J., Takeda, K., Teng, M. W. L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.025 · Cited by 388
Self-citationA Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
Ohta, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00109 · Cited by 385
Cronstein, B. N., Levin, R. I., Philips, M., Hirschhorn, R., Abramson, S. B., & Weissmann, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2201 · Cited by 365
Blockade of A 2A receptors potently suppresses the metastasis of CD73 + tumors
Beavis, P. A., Divisekera, U., Paget, C., Chow, M. T., John, L. B., Devaud, C., Dwyer, K., Stagg, J., Smyth, M. J., & Darcy, P. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308209110 · Cited by 345
Self-citationHIF‐dependent induction of adenosine A2B receptor in hypoxia
Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., & Colgan, S. P. (2006) · The FASEB Journal · doi:10.1096/fj.06-6419com · Cited by 335
Mascanfroni, I. D., Yeste, A., Vieira, S. M., Burns, E. J., Patel, B., Sloma, I., Wu, Y., Mayo, L., Ben-Hamo, R., Efroni, S., et al. (2013) · Nature Immunology · doi:10.1038/ni.2695 · Cited by 329
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Beavis, P. A., Henderson, M. A., Giuffrida, L., Mills, J. K., Sek, K., Cross, R. S., Davenport, A. J., John, L. B., Mardiana, S., Slaney, C. Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89455 · Cited by 325
Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
Ohta, A., & Sitkovsky, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00304 · Cited by 320
Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
Young, A., Mittal, D., Stagg, J., & Smyth, M. J. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0341 · Cited by 310
Self-citationCekic, C., Day, Y.-J., Sag, D., & Linden, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3583 · Cited by 304
Targeting CD73 in the tumor microenvironment with MEDI9447
Hay, C. M., Sult, E., Huang, Q., Mulgrew, K., Fuhrmann, S. R., McGlinchey, K. A., Hammond, S. A., Rothstein, R., Rios-Doria, J., Poon, E., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1208875 · Cited by 287
Sun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Müller, C. E., Murakami, T., & Robson, S. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.007 · Cited by 279
Adenosine A 2A Receptor as a Drug Discovery Target
de Lera Ruiz, M., Lim, Y.-H., & Zheng, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011669 · Cited by 276
Zhang, B., Wang, Z., Wu, L., Zhang, M., Li, W., Ding, J., Zhu, J., Wei, H., & Zhao, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057114 · Cited by 269
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
Wang, L., Fan, J., Thompson, L. F., Zhang, Y., Shin, T., Curiel, T. J., & Zhang, B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45559 · Cited by 262
CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors
Kalekar, L. A., Schmiel, S. E., Nandiwada, S. L., Lam, W. Y., Barsness, L. O., Zhang, N., Stritesky, G. L., Malhotra, D., Pauken, K. E., Linehan, J. L., et al. (2016) · Nature Immunology · doi:10.1038/ni.3331 · Cited by 260
CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
Turcotte, M., Spring, K., Pommey, S., Chouinard, G., Cousineau, I., George, J., Chen, G. M., Gendoo, D. M. A., Haibe-Kains, B., Karn, T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3569 · Cited by 257
Cortez, V. S., Cervantes-Barragan, L., Robinette, M. L., Bando, J. K., Wang, Y., Geiger, T. L., Gilfillan, S., Fuchs, A., Vivier, E., Sun, J. C., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.007 · Cited by 255
Sitkovsky, M. V., Kjaergaard, J., Lukashev, D., & Ohta, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0229 · Cited by 253
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Mittal, D., Young, A., Stannard, K., Yong, M., Teng, M. W. L., Allard, B., Stagg, J., & Smyth, M. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0957 · Cited by 245
Self-citationBastid, J., Regairaz, A., Bonnefoy, N., Déjou, C., Giustiniani, J., Laheurte, C., Cochaud, S., Laprevotte, E., Funck-Brentano, E., Hemon, P., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0018 · Cited by 240
Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., & Sitkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901247 · Cited by 215
Hatfield, S. M., Kjaergaard, J., Lukashev, D., Belikoff, B., Schreiber, T. H., Sethumadhavan, S., Abbott, R., Philbrook, P., Thayer, M., Shujia, D., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1189-3 · Cited by 211
CD73-Deficient Mice Are Resistant to Carcinogenesis
Stagg, J., Beavis, P. A., Divisekera, U., Liu, M. C. P., Möller, A., Darcy, P. K., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0420 · Cited by 211
Self-citationAdenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
Cekic, C., Sag, D., Li, Y., Theodorescu, D., Strieter, R. M., & Linden, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101845 · Cited by 201
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Leclerc, B. G., Charlebois, R., Chouinard, G., Allard, B., Pommey, S., Saad, F., & Stagg, J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1181 · Cited by 200
Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells
Wang, L., Zhou, X., Zhou, T., Ma, D., Chen, S., Zhi, X., Yin, L., Shao, Z., Ou, Z., & Zhou, P. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0292-z · Cited by 196
Rao, S. R., Snaith, A. E., Marino, D., Cheng, X., Lwin, S. T., Orriss, I. R., Hamdy, F. C., & Edwards, C. M. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.402 · Cited by 179
High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
Wu, X., He, X., Chen, Y., Yuan, R., Zeng, Y., Lian, L., Zou, Y., Lan, N., Wu, X., & Lan, P. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23056 · Cited by 178
Gs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells
Raskovalova, T., Huang, X., Sitkovsky, M., Zacharia, L. C., Jackson, E. K., & Gorelik, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4383 · Cited by 175
del Barrio, I. M., Penski, C., Schlahsa, L., Stein, R. G., Diessner, J., Wöckel, A., Dietl, J., Lutz, M. B., Mittelbronn, M. G. A., Wischhusen, J., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0154-9 · Cited by 175
Anti‐CD73 therapy impairs tumor angiogenesis
Allard, B., Turcotte, M., Spring, K., Pommey, S., Royal, I., & Stagg, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.28456 · Cited by 171
Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer
Inoue, Y., Yoshimura, K., Kurabe, N., Kahyo, T., Kawase, A., Tanahashi, M., Ogawa, H., Inui, N., Funai, K., Shinmura, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14434 · Cited by 169
Reinhardt, J., Landsberg, J., Schmid-Burgk, J. L., Ramis, B. B., Bald, T., Glodde, N., Lopez-Ramos, D., Young, A., Ngiow, S. F., Nettersheim, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0395 · Cited by 169
Self-citationLymphatic transport of exosomes as a rapid route of information dissemination to the lymph node
Srinivasan, S., Vannberg, F. O., & Dixon, J. B. (2016) · Scientific Reports · doi:10.1038/srep24436 · Cited by 167
Generation of anti‐inflammatory adenosine byleukocytes is regulated by TGF‐β
Regateiro, F. S., Howie, D., Nolan, K. F., Agorogiannis, E. I., Greaves, D. R., Cobbold, S. P., & Waldmann, H. (2011) · European Journal of Immunology · doi:10.1002/eji.201141512 · Cited by 166
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
Mittal, D., Sinha, D., Barkauskas, D., Young, A., Kalimutho, M., Stannard, K., Caramia, F., Haibe-Kains, B., Stagg, J., Khanna, K. K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0544 · Cited by 161
Self-citationMerighi, S., Mirandola, P., Milani, D., Varani, K., Gessi, S., Klotz, K., Leung, E., Baraldi, P. G., & Borea, P. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00111.x · Cited by 158
Iannone, R., Miele, L., Maiolino, P., Pinto, A., & Morello, S. (2013) · Neoplasia · doi:10.1593/neo.131748 · Cited by 156
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
Waickman, A. T., Alme, A., Senaldi, L., Zarek, P. E., Horton, M. R., & Powell, J. D. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1155-7 · Cited by 155
CD73–Adenosine: A Next-Generation Target in Immuno-Oncology
Allard, D., Allard, B., Gaudreau, P.-O., Chrobák, P., & Stagg, J. (2016) · Immunotherapy · doi:10.2217/imt.15.106 · Cited by 153
Host A2B Adenosine Receptors Promote Carcinoma Growth
Ryzhov, S. V., Novitskiy, S. V., Carbone, D. P., Biaggioni, I., Zaynagetdinov, R., Goldstein, A. E., Dikov, M. M., & Feoktistov, I. (2008) · Neoplasia · doi:10.1593/neo.08478 · Cited by 151
Zhi, X., Chen, S., Zhou, P., Shao, Z., Wang, L., Ou, Z., & Yin, L. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9081-y · Cited by 149
Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
Li, L., Huang, L., Ye, H., Song, S., Bajwa, A., Lee, S. J., Moser, E. K., Jaworska, K., Kinsey, G. R., Day, Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63170 · Cited by 149
Phenotypic and functional characteristics of CD39highhuman regulatory B cells (Breg)
Figueiró, F., Müller, L., Funk, S., Jackson, E. K., Battastini, A. M. O., & Whiteside, T. L. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1082703 · Cited by 147
Feng, L., Sun, X., Csizmadia, E., Han, L., Shu, B., Murakami, T., Wang, X., Robson, S. C., & Wu, Y. (2011) · Neoplasia · doi:10.1593/neo.101332 · Cited by 145
Serra, S., Horenstein, A. L., Vaisitti, T., Brusa, D., Rossi, D., Laurenti, L., D'Arena, G. F., Coscia, M., Tripodo, C., Inghirami, G., et al. (2011) · Blood · doi:10.1182/blood-2011-08-374728 · Cited by 142
Terp, M. G., Olesen, K. A., Arnspang, E. C., Lund, R. R., Lagerholm, B. C., Ditzel, H. J., & Leth‐Larsen, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301274 · Cited by 141
Activation of Adenosine 2A Receptors Attenuates Allograft Rejection and Alloantigen Recognition
Sevigny, C. P., Li, L., Awad, A. S., Huang, L., MCDUFFIE, M. J., Linden, J. M., Lobo, P. I., & Okusa, M. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4240 · Cited by 141
Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
Hung, S.-P., Yang, M.-H., Tseng, K.-F., & Lee, O. K. (2013) · Cell Transplantation · doi:10.3727/096368912x657954 · Cited by 137
Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model.
Iannone, R., Miele, L., Maiolino, P., Pinto, A., & Morello, S. (2014) · Europe PMC (PubMed Central) · Cited by 129
Role of TGF-β Signaling in Generation of CD39+CD73+ Myeloid Cells in Tumors
Ryzhov, S. V., Pickup, M. W., Chytil, A., Gorska, A. E., Zhang, Q., Owens, P., Feoktistov, I., Moses, H. L., & Novitskiy, S. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400578 · Cited by 126
Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma
Lu, X.-X. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i12.1912 · Cited by 120
NAD+-Metabolizing Ectoenzymes in Remodeling Tumor–Host Interactions: The Human Myeloma Model
Horenstein, A. L., Chillemi, A., Quarona, V., Zito, A., Roato, I., Morandi, F., Marimpietri, D., Bolzoni, M., Toscani, D., Oldham, R. J., et al. (2015) · Cells · doi:10.3390/cells4030520 · Cited by 116
Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4393 · Cited by 113
Geoghegan, J. C., Diedrich, G., Lu, X., Rosenthal, K., Sachsenmeier, K. F., Wu, H., Dall’Acqua, W. F., & Damschroder, M. M. (2016) · mAbs · doi:10.1080/19420862.2016.1143182 · Cited by 113
Extracellular adenosine regulates naive T cell development and peripheral maintenance
Cekic, C., Sağ, D., Day, Y., & Linden, J. M. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130249 · Cited by 111
Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma
Sądej, R., Spychała, J., & Składanowski, A. C. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000215030.69823.11 · Cited by 106
Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C., & Robson, S. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070190 · Cited by 104
Kolachala, V. L., Asamoah, V., Wang, L., Obertone, T. S., Ziegler, T. R., Merlin, D., & Sitaraman, S. V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5328-4 · Cited by 103
Xu, S., Shao, Q., Sun, J., Yang, N., Xie, Q., Wang, D., Huang, Q., Huang, B., Wang, X., Li, X., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not067 · Cited by 103
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Young, A., Ngiow, S. F., Madore, J., Reinhardt, J., Landsberg, J., Chitsazan, A., Rautela, J., Bald, T., Barkauskas, D. S., Ahern, E. S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0393 · Cited by 103
Self-citationAgonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell–Rich Tumor
Ngiow, S. F., Young, A., Blake, S. J., Hill, G. R., Yagita∥, H., Teng, M. W. L., Korman, A. J., & Smyth, M. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2141 · Cited by 101
Self-citationPettengill, M. A., Robson, S. C., Tresenriter, M., Millán, J. L., Usheva, A., Bingham, T. C., Belderbos, M. E., Bergelson, I., Burl, S., Kampmann, B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484212 · Cited by 99
Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
Bowser, J. L., Blackburn, M. R., Shipley, G. L., Molina, J. G., Dunner, K., & Broaddus, R. R. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79380 · Cited by 97
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
Takedachi, M., Qu, D., Ebisuno, Y., Oohara, H., Joachims, M. L., McGee, S. T., Maeda, E., McEver, R. P., Tanaka, T. T., Miyasaka, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6288 · Cited by 93
Sun, X., Han, L., Seth, P., Shu, B., Li, L., Csizmadia, E., JUNGER, W. G., Schmelzle, M., Usheva, A., Tapper, E. B., et al. (2012) · Hepatology · doi:10.1002/hep.25989 · Cited by 90
Hilchey, S. P., Kobie, J. J., Cochran, M. R., Secor‐Socha, S., Wang, J.-C. E., Hyrien, O., Burack, R., Mosmann, T. R., Quataert, S. A., & Bernstein, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900475 · Cited by 87
Mora‐García, M. D. L., García‐Rocha, R., Morales-Ramírez, O., Montesinos, J. J., Weiss‐Steider, B., Hernández‐Montes, J., Ávila-Ibarra, L. R., Don‐López, C. A., Velasco-Velázquez, M. A., Gutiérrez-Serrano, V., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1057-8 · Cited by 85
Airas, L. M., Niemelä, J., & Jalkanen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5411 · Cited by 84
Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune Regulation
Klein, M., & Bopp, T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00315 · Cited by 84
Morello, S., Ito, K., Yamamura, S., Lee, K., Jazrawi, E., deSouza, P., Barnes, P. J., Cicala, C., & Adcock, I. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7173 · Cited by 80
Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
Kim, S. H., Shin, K.-H., Moon, S., Jang, J., Kim, H. S., Suh, J., & Yang, W. (2017) · Cancer Medicine · doi:10.1002/cam4.1022 · Cited by 79
CD73 is associated with poor prognosis in HNSCC
Ren, Z., Lin, C., Cao, W., Yang, R., Lu, W., Liu, Z., Chen, Y., Yang, X., Tian, Z., Wang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11435 · Cited by 78
Armstrong, J. M., Chen, J., Schwarzschild, M. A., Apasov, S. G., Smith, P. T., Caldwell, C. C., Pearl, C. H. E. N., Figler, H., Sullivan, G. W., Steven, F. I. N. K., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540123 · Cited by 76
Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor
Moriyama, K., & Sitkovsky, M. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098293 · Cited by 74
Cai, X., Ni, X., Yi, Y., He, H.-W., Wang, J., Fu, Y., Sun, J., Zhou, J., Cheng, Y., Jin, J., et al. (2016) · Medicine · doi:10.1097/md.0000000000004989 · Cited by 74
Adenosine Receptors and Angiogenesis
Auchampach, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.165761 · Cited by 73
Choi, H. S., Ha, S. Y., Kim, H., Ahn, S. M., Kang, M.-S., Kim, K., Choi, M. G., Lee, J. H., Sohn, T. S., Bae, J. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6958 · Cited by 72
The NAD+ salvage pathway modulates cancer cell viability via p73
Sharif, T., Ahn, D.-G., Liu, R.-Z., Pringle, E. S., Martell, E., Dai, C., Nunokawa, A., Kwak, M., Clements, D. R., Murphy, J. P., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.134 · Cited by 70
Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis
Yang, Q., Du, J., & Zu, L. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9648-7 · Cited by 68
Tak, E., Jung, D., Kim, S., Park, G., Jun, D. Y., Lee, J., Jung, B.-H., Kirchner, V. A., Hwang, S., Song, G., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.11.016 · Cited by 68
Fernández, P., Pérez‐Aso, M., Smith, G. P., Wilder, T., Trzaska, S., Chiriboga, L. A., Franks, A. G., Robson, S. C., Cronstein, B. N., & Chan, E. S. L. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.024 · Cited by 60
The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma
Zhang, B., Song, B., Wang, X., Chang, X., Pang, T., Zhang, X., Yin, K., & Fang, G. (2015) · Tumor Biology · doi:10.1007/s13277-015-3212-x · Cited by 59
Vecchio, E. A., Tan, C. Y. R., Gregory, K. J., Christopoulos, A., White, P. J., & May, L. T. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.230003 · Cited by 59
Extracellular Adenosine Sensing—A Metabolic Cell Death Priming Mechanism Downstream of p53
Long, J. S., Crighton, D., O’Prey, J., Mackay, G., Zheng, L., Palmer, T. M., Gottlieb, E., & Ryan, K. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.03.016 · Cited by 54
Flament (2009) · Oncology Reports · doi:10.3892/or_00000311 · Cited by 49
Prostatic acid phosphatase, a neglected ectonucleotidase
Zimmermann, H. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9157-z · Cited by 47
Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11729 · Cited by 45
Tan, E. Y., Mujoomdar, M., & Blay, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63299-3 · Cited by 41
Butler, M., Sanmugalingam, D., Burton, V. J., Wilson, T., Pearson, R., Watson, R. P., SMITH, P. F., & Parkinson, S. J. (2012) · European Journal of Immunology · doi:10.1002/eji.201242655 · Cited by 36
Cai, X., Wang, X., Li, J., Dong, J., Liu, J., Li, N.-P., Yun, B., & Xia, R. (2015) · PubMed Central · Cited by 35
Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens
Gruenbacher, G., Gander, H., Rahm, A., Idzko, M., Nussbaumer, O., & Thurnher, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.009 · Cited by 31
Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases
Vijayan, D., Barkauskas, D. S., Stannard, K. A., Sult, E., Buonpane, R. A., Takeda, K., Teng, M. W. L., Sachsenmeier, K. F., Hay, C. M., & Smyth, M. J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1312044 · Cited by 30
Self-citationNAD+‐metabolizing ecto‐enzymes shape tumor–host interactions: The chronic lymphocytic leukemia model
Vaisitti, T., Audrito, V., Serra, S., Bologna, C., Brusa, D., Malavasi, F., & Deaglio, S. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.036 · Cited by 29
Borodovsky, A., Wang, Y., Ye, M., Shaw, J. C., Sachsenmeier, K. F., Deng, N., DelSignore, K. J., Fretland, A. J., Clarke, J. D., Goodwin, R. J. A., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-5580 · Cited by 27
Fons, P., Esquerré, M., Versluys, S., Mambrini, G., Paillasse, M. R., Bell, A., Schreyer, A. M., Cox, R., Bickerton, R., Lisztwan, J. H., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-3970 · Cited by 5
Cited by
Single-cell reconstruction of the early maternal–fetal interface in humans
Vento-Tormo, R., Efremova, M., Botting, R. A., Turco, M. Y., Vento-Tormo, M., Meyer, K. B., Park, J.-E., Stephenson, E., Polański, K., Goncalves, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0698-6 · Cited by 2,358
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Self-citationCD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Farhood, B., Najafi, M., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27782 · Cited by 1,658
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
Self-citation
Metadata
- Authors
- Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J.
- Venue
- Nature Reviews Cancer
- Published
- 2017-12
- Volume
- 17
- Issue
- 12
- Pages
- 709-724
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2765132620
- Cited by
- 840
- References
- 133
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.